Background: No case of leukoencephalopathy has been reported associated with multiple myeloma.
Introduction
Neurological complications of multiple myeloma include spinal cord or root compressions, cranial nerve palsies and peripheral neuropathies related to nerve ischemia and myelomatous or amyloid infiltration. Leukoencephalopathy has been described as a paraneoplastic syndrome in association with chronic lymphocytic leukemia, Hodgkin's disease or lymphosarcoma, but has not been found to be associated with multiple myeloma. We report two cases with these two associated pathologies which probably constitute a cerebral localization of malignant dysglobulinemia.
Case report 1
A 66-year-old man was admitted to the neurological department for distal weakness of upper limbs and paresthesia. He had no medical history (i.e., hypertension, diabetes) or neurological symptoms. He presented, with a two-month history, a diffuse amyotrophia and a mild proprioceptive ataxia. The patient complained of a discreet impairment of higher cortical functions, especially memory loss and difficulties of concentration (Mini Mental State 28/30). Tendon reflexes were absent in the arms but present and symmetrical in his legs. There was no Babinski sign and sensory testing (i.e., touch, pinprick, vibration and joint position) were normal. Laboratory tests showed a normal blood count with a high sedimentation rate (50/70-Normal <5) and increased P2 microglobulin (5-Normal < 3). There was no renal insufficiency or hypercalcemia. Serum immunoelectrophoresis showed a monoclonal IgG-A. gammaglobulin peak (21.6g/l-Normal = 6.5-14), with low IgA and IgM fractions. Urine analysis revealed a monoclonal Bence Jones proteinuria. Chemical and bacteriological examinations of cerebrospinal fluid (CSF) obtained by lumbar puncture were normal, and cellular analysis found only 4 leukocytes/mm 3 with 44% of lymphocytes (Table 1) . CSF electrophoresis isolated the same intrathecal secretion of monoclonal IgG-A. protein, excluding a transudate (qualitative and quantitative levels). Polymerase chain reaction for JC virus was negative. Antibodies to myelin associated protein were negative. Electromyographic studies showed a significant slowing down of motor and sensory nerve conduction velocities in median and sural nerves, reduction in amplitude and increased distal latencies. Taken together, these measurements confirmed a generalized peripheral mixed polyneuropathy. Sural nerve biopsy showed subacute myelin degeneration without amyloid component deposit. However, an immunofluorescence study revealed binding of anti-IgG and anti-X. antibodies to myelin sheaths. The diagnosis of multiple myeloma was confirmed by the presence of a bone marrow plasma cell infiltrate (45%). Accessory salivary gland and rectal biopsies failed to detect associated amyloidosis. Computerized tomographic scan of the brain, performed to explain the mild changes in mental status and the intrathecal IgGA secretion, showed diffuse white matter abnormalities. Magnetic resonance imaging (MRI) revealed a diffuse leukoencephalopathy with the presence in the T 2 -weighted sequence of numerous bihemispheric hypersignals (Figure la) . There was no enhancement after Gadolinium injection in T r weighted sequences. No other pathology was found to explain the leukoencephalopathy. Treatment with Melphalan (10 mg/d for four days/month) and prednisone (1 mg/kg/day) was started. After three courses of treatment, his subjective sensory disorders and ataxia had disappeared; all his tendon reflexes had also reappeared. Biological tests showed normal CSF values and serum IgG levels, with diminution of the bone marrow plasmocytosis (19%). Further MRI studies performed 3, 6 and 12 months later confirmed stabilization of the white matter lesions.
Case report 2
A 70-year-old woman was admitted to the neurological department of the Pasteur Hospital for asthenia, disorientation, headaches and vertigo. She had chronic renal failure (urea: 20 mmol/1-Normal: 2.5-7.5; creatinin: 220 umol/1-Normal: 45-90) without hypertension or other medical history. Three months previously, she had been initially treated for a proplasmacytic multiple myeloma. She had already had three cycles of Melphalan (10 mg/d; four days/month) and prednisone (1 mg/kg/day) when her neurological symptoms appeared. Blood count showed mild thrombopenia (110,000/mm Figure lb) . After six courses of treatment, examination showed normal serum and CSF IgG levels. Her headaches and vertigo disappeared within 10 days.
Discussion
In these two cases, the association of diffuse leukoencephalopathy, myelinic polyneuropathy and multiple myeloma suggests a probable relationship between all features, which appears to be unusual in multiple myeloma as no similar case has been reported in the literature. Leukoencephalopathy is characterized by widespread lesions of demyelination, mainly of the cerebral hemispheres but also of the brainstem and cerebellum, rarely of the spinal cord (Table 2) . It is more often associated with chronic neoplasia: chronic lymphocytic leukemia, Hodgkin's disease, lymphosarcoma and, more rarely, myeloproliferative disease [1] . The use of prednisone and alkylating agents sometimes leads to an improvement in the general and neurological symptoms, but with incomplete recovery. In cases of solitary plasmacytoma, radiotherapy may result in prolonged remission of both the myeloma and neuropathy [2] . The first case reported here fits with the diagnosis of an associated myelomatous neuropathy. Subacute or chronic distal sensorimotor polyneuropathies (PN) are common in multiple myeloma and have a high association with the osteosclerotic form. These clinical forms of PN are seen clinically in 5% to 14% of myeloma [3, 4] . Although an IgG-?*. component was isolated in CSF, the etiology of the white matter changes seen on MRI is unclear without histopathological proof. The fact that leukoencephalopathy and cognitive impairment did not worsen or were stabilized by prompt specific treatment for multiple myeloma strengthens the hypothesis that the leukoencephalopathy is directly related to myeloma. We venture to suggest that the leukoencephalopathy is probably a direct cerebral expression of malignant gammopathy. In both cases, absence of Gadolinium enhancement in T r weighted MRI reflects blood brain barrier integrity. Intrathecal secretion of monoclonal protein could be responsible for the leukoencephalopathy. However, we cannot exclude the possibility that it represents a combined paraneoplastic syndrome or a fortuitous association. While the development of the different neurological symptoms may vary, prompt systemic treatment is necessary in all cases in order to achieve stabilization or improvement of neurological symptoms.
The incidence increases significantly (40%) when subclinical neuropathy based on nerve conduction studies is included. Histologic examination of peripheral nerves demontrates that the primary pathologic lesions are axonal degeneration and demyelination. Numerous theories exist as to the origin of neurologic changes in cases where there is no evidence of anatomical involvement between the tumor mass and neighbouring neural structures. These theories include amyloidosis, ischemia, toxic metabolic factors (circulating abnormal protein or immunoglobulin fragment) and myelin antibodies. Other neurological syndromes have been reported in multiple myeloma such as motor neuropathies [5] , Guillain-Barre syndrome, isolated or multiple cranial nerve palsies [6, 7] , benign intracranial hypertension [8] , spinal cord compressions [9] , meningeal involvement [10] or strokes due to rheologic abnormalities (Table 3) . Myelomatous PN are predominantly distal, characterized by severe weakness, ataxia and sensory loss in the upper and lower limbs. Usually, they are characterized by alternating remissions and relapses with muscular atrophy increasing over a period of several months. Ataxia can be pronounced when sensory loss exceeds paresis. Few patients with myeloma have osteosclerotic lesions, but over half of those with sclerotic lesions have neuropathy. Furthermore, the paraprotein is usually an IgA or IgG in small concentrations, almost always with a lambda light chain [11] . The neuropathies associated with sclerotic myeloma are likely to become severe and the cerebrospinal fluid protein level tends to be very high. Although multiple myeloma can be associated with amyloidosis or with paraneoplastic neuropathy [12] , amyloid neuropathy is seen in approximately 10% to 15% of patients. In the first case report , chemotherapy improved the neurological and biological signs and MRIs
